TAK-659 (hydrochloride)(1952251-28-3)
- Name: TAK-659 (hydrochloride)
- Synonyms:6-(((1R,2S)-2-Aminocyclohexyl)amino)-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one hydrochloride;CS-2611;TAK659;TAK 659;TAK-659;TAK-659 (hydrochloride);TAK-659 HCl;6-{[(1R,2S)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1H,2H,3H-pyrrolo[3,4-c]pyridin-3-one hydrochloride;Spleen,Inhibitor,Spleen tyrosine kinase,TAK659,Cluster of differentiation antigen 135,inhibit,CLL,related,tyrosine,kinase,FLT3,Fms like tyrosine kinase 3,CD135,TAK 659 hydrochloride,TAK659 hydrochloride,fms,Syk,TAK 659;TAK-659 hydrochloride (Mivavotinib
- Molecular Formula:C17H22ClFN6O
- Molecular Weight:380.85
- CAS Registry Number:1952251-28-3
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1951451-56-1/4-methoxy-6-((tetrahydro-2H-pyran-4-yl)oxy)pyridin-3-amine
- 1951451-63-0/tert-butyl 4-(2-amino-2-oxoethyl)-3-oxopiperazine-1-carboxylate
- 1951451-76-5/3-(tert-butyl)-1-(isoquinolin-6-yl)-1H-pyrazol-5-aMine
- 1951451-82-3/3-(3,5-dibromo-4-methoxybenzoyl)-2-ethylbenzofuran-6-sulfonyl chloride
- 1951459-69-0/Carbamic acid, N-[(3S,4R)-3-aminotetrahydro-2H-pyran-4-yl]-, 1,1-dimethylethyl ester
- 1951464-79-1/CL656
- 1951467-28-9/Canagliflozin Impurity 17
- 1951483-74-1/6,6-dimethyl-5,6-dihydro-4H-thieno[2,3-c]pyrrol-4-one
- 1951483-78-5/5H-Thieno[2,3-c]pyrrole-5-carboxylic acid, 2-bromo-4,6-dihydro-6,6-dimethyl-4-oxo-, 1,1-dimethylethyl ester
- 1951483-79-6/5H-Thieno[2,3-c]pyrrole-5-carboxylic acid, 4,6-dihydro-6,6-dimethyl-4-oxo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester
- 195157-66-5/Phenol,4-[(4-cyclopropyl-6-methyl-2-pyrimidinyl)amino]-
- 195189-66-3/1H-1,2,4-Triazole-5-methanol, α-methyl-3-phenyl-
- 195199-08-7/Quinolinium, 2-[[2-(dimethylamino)ethyl]thio]-4-[(3-methyl-2(3H)-benzoxazolylidene)methyl]-1-phenyl-, iodide (1:1)
- 195201-10-6/3-Bromo-4-chlorobenzenesulfonyl chloride
- 195205-10-8/2-Propenoic acid, 2-methylbutyl ester, polymer with 2-propenamide
- 195207-76-2/3-Hydroxyhexadecanoylcarnitine
- 195211-62-2/Y627
- 1952239-59-6/1H-Benzimidazole-5-sulfonamide, N-(2,4-dimethylphenyl)-2,3-dihydro-N-(2-methylpropyl)-2-oxo-1-[(tetrahydro-2H-pyran-4-yl)methyl]-
- 1952247-05-0/1H-Benzimidazole-5-sulfonamide, 1-[(2,4-dimethyl-5-thiazolyl)methyl]-2,3-dihydro-N-(1-methylcyclopropyl)-2-oxo-3-(1,2,4-thiadiazol-5-yl)-
- 1952251-28-3/TAK-659 (hydrochloride)
- 1952254-01-1/1-thia-6-azaspiro[3.4]octane 1,1-dioxide hydrochloride
- 1952254-07-7/2-thia-7-azaspiro[4.4]nonane 2,2-dioxide hydrochloride
- 1952262-16-6/5-Chloro-7-fluoro-quinoline
- 1952272-74-0/Bemarituzumab
- 1952276-60-6/4,7-Dimethylbenzofuran-2-carboxylic acid hydrazide
- 1952294-70-0/4-Piperidinemethanol, 3-fluoro-, hydrochloride (1:1), (3S,4R)-
- 1952294-71-1/tert-butyl (3S,4R)-4-(aminomethyl)-3-fluoropiperidine-1-carboxylate
- 1952294-75-5/1-Piperidinecarboxylic acid, 3-fluoro-4-(hydroxymethyl)-, (4-methylphenyl)methyl ester, (3S,4R)-
- 1952305-76-8/1,2,4,5-Tetrazine-3-methanamine, 6-methyl-, 2,2,2-trifluoroacetate (1:1)
- 1952307-22-0/1-(Difluoromethyl)-1H-pyrazol-5-amine